Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension

Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rinshō yakuri 2006, Vol.37 (1), p.49-54, Article 49
Hauptverfasser: TANIGUCHI, Ikuo, NAKAE, Sahachiro, DATE, Taro, YOSHIDA, Satoru, SEKI, Shingo, TANIGUCHI, Masayuki, SHIMIZU, Mitsuyuki, MOCHIZUKI, Seibu
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue 1
container_start_page 49
container_title Rinshō yakuri
container_volume 37
creator TANIGUCHI, Ikuo
NAKAE, Sahachiro
DATE, Taro
YOSHIDA, Satoru
SEKI, Shingo
TANIGUCHI, Masayuki
SHIMIZU, Mitsuyuki
MOCHIZUKI, Seibu
description
doi_str_mv 10.3999/jscpt.37.49
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_citationtrail_10_3999_jscpt_37_49</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>n/a</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2759-44c548277356947e160502f1489b5253b238d9017b2452bc7fc59455f6572b903</originalsourceid><addsrcrecordid>eNptkMtOwzAURC0EEqWw4ge8RymOH3G8bFGhlYpAPNaR49iN22BHtgH1Q_hf0sIKsboaac6M7gBwmaMJEUJcb6Lq04TwCRVHYJQzgrOCEXYMRgghkQlMilNwFuNmkFSU5Qh8TZvGJvuh4dwYrVKE3sDn3gbvfCdV8k7D5OHUra1P2kXr4HIJn7TSffIBzjqvtjrA-8GeWh1kv4PewWnX-Jh02NOzoOU2tcG_r1s44I8yWe2Gok-bWjiPcRBWdnCx63U4VHh3Dk6M7KK--L1j8Ho7f7lZZKuHu-XNdJUpzJnIKFWMlphzwgpBuc4LxBA2OS1FzTAjNSZlI1DOa0wZrhU3ignKmCkYx7VAZAyufnJV8DEGbao-2DcZdlWOqv2i1WHRivCKisGd_3Erm4ZvvEtB2u5f5hut3X3e</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>TANIGUCHI, Ikuo ; NAKAE, Sahachiro ; DATE, Taro ; YOSHIDA, Satoru ; SEKI, Shingo ; TANIGUCHI, Masayuki ; SHIMIZU, Mitsuyuki ; MOCHIZUKI, Seibu</creator><creatorcontrib>TANIGUCHI, Ikuo ; NAKAE, Sahachiro ; DATE, Taro ; YOSHIDA, Satoru ; SEKI, Shingo ; TANIGUCHI, Masayuki ; SHIMIZU, Mitsuyuki ; MOCHIZUKI, Seibu</creatorcontrib><identifier>ISSN: 0009-9236</identifier><identifier>ISSN: 0388-1601</identifier><identifier>EISSN: 1532-6535</identifier><identifier>EISSN: 1882-8272</identifier><identifier>DOI: 10.3999/jscpt.37.49</identifier><language>eng</language><ispartof>Rinshō yakuri, 2006, Vol.37 (1), p.49-54, Article 49</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2759-44c548277356947e160502f1489b5253b238d9017b2452bc7fc59455f6572b903</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,27902</link.rule.ids></links><search><creatorcontrib>TANIGUCHI, Ikuo</creatorcontrib><creatorcontrib>NAKAE, Sahachiro</creatorcontrib><creatorcontrib>DATE, Taro</creatorcontrib><creatorcontrib>YOSHIDA, Satoru</creatorcontrib><creatorcontrib>SEKI, Shingo</creatorcontrib><creatorcontrib>TANIGUCHI, Masayuki</creatorcontrib><creatorcontrib>SHIMIZU, Mitsuyuki</creatorcontrib><creatorcontrib>MOCHIZUKI, Seibu</creatorcontrib><title>Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension</title><title>Rinshō yakuri</title><issn>0009-9236</issn><issn>0388-1601</issn><issn>1532-6535</issn><issn>1882-8272</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptkMtOwzAURC0EEqWw4ge8RymOH3G8bFGhlYpAPNaR49iN22BHtgH1Q_hf0sIKsboaac6M7gBwmaMJEUJcb6Lq04TwCRVHYJQzgrOCEXYMRgghkQlMilNwFuNmkFSU5Qh8TZvGJvuh4dwYrVKE3sDn3gbvfCdV8k7D5OHUra1P2kXr4HIJn7TSffIBzjqvtjrA-8GeWh1kv4PewWnX-Jh02NOzoOU2tcG_r1s44I8yWe2Gok-bWjiPcRBWdnCx63U4VHh3Dk6M7KK--L1j8Ho7f7lZZKuHu-XNdJUpzJnIKFWMlphzwgpBuc4LxBA2OS1FzTAjNSZlI1DOa0wZrhU3ignKmCkYx7VAZAyufnJV8DEGbao-2DcZdlWOqv2i1WHRivCKisGd_3Erm4ZvvEtB2u5f5hut3X3e</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>TANIGUCHI, Ikuo</creator><creator>NAKAE, Sahachiro</creator><creator>DATE, Taro</creator><creator>YOSHIDA, Satoru</creator><creator>SEKI, Shingo</creator><creator>TANIGUCHI, Masayuki</creator><creator>SHIMIZU, Mitsuyuki</creator><creator>MOCHIZUKI, Seibu</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2006</creationdate><title>Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension</title><author>TANIGUCHI, Ikuo ; NAKAE, Sahachiro ; DATE, Taro ; YOSHIDA, Satoru ; SEKI, Shingo ; TANIGUCHI, Masayuki ; SHIMIZU, Mitsuyuki ; MOCHIZUKI, Seibu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2759-44c548277356947e160502f1489b5253b238d9017b2452bc7fc59455f6572b903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>TANIGUCHI, Ikuo</creatorcontrib><creatorcontrib>NAKAE, Sahachiro</creatorcontrib><creatorcontrib>DATE, Taro</creatorcontrib><creatorcontrib>YOSHIDA, Satoru</creatorcontrib><creatorcontrib>SEKI, Shingo</creatorcontrib><creatorcontrib>TANIGUCHI, Masayuki</creatorcontrib><creatorcontrib>SHIMIZU, Mitsuyuki</creatorcontrib><creatorcontrib>MOCHIZUKI, Seibu</creatorcontrib><collection>CrossRef</collection><jtitle>Rinshō yakuri</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TANIGUCHI, Ikuo</au><au>NAKAE, Sahachiro</au><au>DATE, Taro</au><au>YOSHIDA, Satoru</au><au>SEKI, Shingo</au><au>TANIGUCHI, Masayuki</au><au>SHIMIZU, Mitsuyuki</au><au>MOCHIZUKI, Seibu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension</atitle><jtitle>Rinshō yakuri</jtitle><date>2006</date><risdate>2006</risdate><volume>37</volume><issue>1</issue><spage>49</spage><epage>54</epage><pages>49-54</pages><artnum>49</artnum><issn>0009-9236</issn><issn>0388-1601</issn><eissn>1532-6535</eissn><eissn>1882-8272</eissn><doi>10.3999/jscpt.37.49</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Rinshō yakuri, 2006, Vol.37 (1), p.49-54, Article 49
issn 0009-9236
0388-1601
1532-6535
1882-8272
language eng
recordid cdi_crossref_citationtrail_10_3999_jscpt_37_49
source Wiley Online Library Journals Frontfile Complete
title Additive Effects of Spironolactone to Angiotensin II Receptor Blocker Monotherapy on Aldosterone Breakthrough in Patients with Essential Hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A50%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Additive%20Effects%20of%20Spironolactone%20to%20Angiotensin%20II%20Receptor%20Blocker%20Monotherapy%20on%20Aldosterone%20Breakthrough%20in%20Patients%20with%20Essential%20Hypertension&rft.jtitle=Rinsho%CC%84%20yakuri&rft.au=TANIGUCHI,%20Ikuo&rft.date=2006&rft.volume=37&rft.issue=1&rft.spage=49&rft.epage=54&rft.pages=49-54&rft.artnum=49&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.3999/jscpt.37.49&rft_dat=%3Ccrossref%3En/a%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true